Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

The classification of Regenerative Medicine includes Cell Therapy and Tissue Engineering, Biomaterial and Others, and the proportion of Tissue Engineering is about 41% in 2017, and the proportion is in increasing trend from 2013 to 2017.

According to this study, over the next five years the Regenerative Medicine market will register a 19.3% CAGR in terms of revenue, the global market size will reach US$ 47800 million by 2024, from US$ 19800 million in 2019. In particular, this report presents the global revenue market share of key companies in Regenerative Medicine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Regenerative Medicine market by product type, application, key companies and key regions.

This study considers the Regenerative Medicine value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

Cell Therapy

Tissue Engineering

Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

Dermatology

Cardiovascular

CNS

Orthopedic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

J & J (DePuy Synthes)

Medtronic

ZimmerBiomet

Stryker

Allergan(Acelity)

MiMedx Group

Organogenesis

Fujifilm Cellular Dynamics

Osiris Therapeutics

Vcanbio

CCBC

Cytori

Celgene

Vericel Corporation

Guanhao Biotech

Mesoblast

AMAG Pharmaceuticals (CBR)

ViaCord

CordLife

Integra LifeSciences

Nuvasive

Cook Biotech

Japan Tissue Engineering

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Regenerative Medicine market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Regenerative Medicine market by identifying its various subsegments.

Focuses on the key global Regenerative Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Regenerative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Regenerative Medicine submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Regenerative Medicine Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Regenerative Medicine Market Size 2014-2024

2.1.2 Regenerative Medicine Market Size CAGR by Region

2.2 Regenerative Medicine Segment by Type

2.2.1 Cell Therapy

2.2.2 Tissue Engineering

2.2.3 Biomaterial

2.2.4 Others

2.3 Regenerative Medicine Market Size by Type

2.3.1 Global Regenerative Medicine Market Size Market Share by Type (2014-2019)

2.3.2 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2019)

2.4 Regenerative Medicine Segment by Application

2.4.1 Dermatology

2.4.2 Cardiovascular

2.4.3 CNS

2.4.4 Orthopedic

2.4.5 Others

2.5 Regenerative Medicine Market Size by Application

2.5.1 Global Regenerative Medicine Market Size Market Share by Application (2014-2019)

2.5.2 Global Regenerative Medicine Market Size Growth Rate by Application (2014-2019)

3 Global Regenerative Medicine by Players

3.1 Global Regenerative Medicine Market Size Market Share by Players

3.1.1 Global Regenerative Medicine Market Size by Players (2017-2019)

3.1.2 Global Regenerative Medicine Market Size Market Share by Players (2017-2019)

3.2 Global Regenerative Medicine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Regenerative Medicine by Regions

4.1 Regenerative Medicine Market Size by Regions

4.2 Americas Regenerative Medicine Market Size Growth

4.3 APAC Regenerative Medicine Market Size Growth

4.4 Europe Regenerative Medicine Market Size Growth

4.5 Middle East & Africa Regenerative Medicine Market Size Growth

5 Americas

5.1 Americas Regenerative Medicine Market Size by Countries

5.2 Americas Regenerative Medicine Market Size by Type

5.3 Americas Regenerative Medicine Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Regenerative Medicine Market Size by Countries

6.2 APAC Regenerative Medicine Market Size by Type

6.3 APAC Regenerative Medicine Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Regenerative Medicine by Countries

7.2 Europe Regenerative Medicine Market Size by Type

7.3 Europe Regenerative Medicine Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Regenerative Medicine by Countries

8.2 Middle East & Africa Regenerative Medicine Market Size by Type

8.3 Middle East & Africa Regenerative Medicine Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Regenerative Medicine Market Forecast

10.1 Global Regenerative Medicine Market Size Forecast (2019-2024)

10.2 Global Regenerative Medicine Forecast by Regions

10.2.1 Global Regenerative Medicine Forecast by Regions (2019-2024)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Regenerative Medicine Forecast by Type

10.8 Global Regenerative Medicine Forecast by Application

11 Key Players Analysis

11.1 J & J (DePuy Synthes)

11.1.1 Company Details

11.1.2 Regenerative Medicine Product Offered

11.1.3 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.1.4 Main Business Overview

11.1.5 J & J (DePuy Synthes) News

11.2 Medtronic

11.2.1 Company Details

11.2.2 Regenerative Medicine Product Offered

11.2.3 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.2.4 Main Business Overview

11.2.5 Medtronic News

11.3 ZimmerBiomet

11.3.1 Company Details

11.3.2 Regenerative Medicine Product Offered

11.3.3 ZimmerBiomet Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.3.4 Main Business Overview

11.3.5 ZimmerBiomet News

11.4 Stryker

11.4.1 Company Details

11.4.2 Regenerative Medicine Product Offered

11.4.3 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.4.4 Main Business Overview

11.4.5 Stryker News

11.5 Allergan(Acelity)

11.5.1 Company Details

11.5.2 Regenerative Medicine Product Offered

11.5.3 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.5.4 Main Business Overview

11.5.5 Allergan(Acelity) News

11.6 MiMedx Group

11.6.1 Company Details

11.6.2 Regenerative Medicine Product Offered

11.6.3 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.6.4 Main Business Overview

11.6.5 MiMedx Group News

11.7 Organogenesis

11.7.1 Company Details

11.7.2 Regenerative Medicine Product Offered

11.7.3 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.7.4 Main Business Overview

11.7.5 Organogenesis News

11.8 Fujifilm Cellular Dynamics

11.8.1 Company Details

11.8.2 Regenerative Medicine Product Offered

11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.8.4 Main Business Overview

11.8.5 Fujifilm Cellular Dynamics News

11.9 Osiris Therapeutics

11.9.1 Company Details

11.9.2 Regenerative Medicine Product Offered

11.9.3 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.9.4 Main Business Overview

11.9.5 Osiris Therapeutics News

11.10 Vcanbio

11.10.1 Company Details

11.10.2 Regenerative Medicine Product Offered

11.10.3 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2019)

11.10.4 Main Business Overview

11.10.5 Vcanbio News

11.11 CCBC

11.12 Cytori

11.13 Celgene

11.14 Vericel Corporation

11.15 Guanhao Biotech

11.16 Mesoblast

11.17 AMAG Pharmaceuticals (CBR)

11.18 ViaCord

11.19 CordLife

11.20 Integra LifeSciences

11.21 Nuvasive

11.22 Cook Biotech

11.23 Japan Tissue Engineering

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Regenerative Medicine

Figure Regenerative Medicine Report Years Considered

Figure Market Research Methodology

F